5 results  1 of 1 

1 Analysis of Reverse Transcriptase Gene Mutations in the Hepatitis B Virus at a University Hospital in Korea
A-Jin Lee, Chang Hyeong Lee, Chang-Ho Jeon
Ann Lab Med.2014;34(3):230-234.   Published online 2014 April 8     DOI: http://dx.doi.org/10.3343/alm.2014.34.3.230
      
2 Hepatitis B Precore Protein: Pathogenic Potential and Therapeutic Promise
Renae Walsh, Stephen Locarnini
Yonsei Med J.2012;53(5):875-885.   Published online 2012 July 25     DOI: http://dx.doi.org/10.3349/ymj.2012.53.5.875
      
3 Clinical Efficacy of a 24-months Course of Lamivudine Therapy in Patients with HBeAg Negative Chronic Hepatitis B: A Long-term Prospective Study
Yong Han Paik, Ja Kyung Kim, Do Young Kim, Jun Yong Park, Sang Hoon Ahn, Kwang-Hyub Han, Chae Yoon Chon, Kwan Sik Lee
J Korean Med Sci.2010;25(6):882-887.   Published online 2010 May 24     DOI: http://dx.doi.org/10.3346/jkms.2010.25.6.882
      
4 Clinical Experience with Long-term Lamivudine Therapy to Determine the Adequate Duration of Treatment in Children and Adolescents with HBeAg-Negative Chronic Hepatitis B
Jung Mi Kim, Suk Jin Hong, Byung Ho Choi, Mi Ae Chu, Seung Man Cho, Byung Ho Choe
Korean J Pediatr Gastroenterol Nutr.2009;12(1):23-29.   Published online 2009 March 31     DOI: http://dx.doi.org/10.5223/kjpgn.2009.12.1.23
      
5 Three Years' Cumulative Therapeutic Efficacy and Long-term Durability of Lamivudine in Korean Children with Chronic Hepatitis B
You Cheol Jang, Min Hyun Cho, Byung Ho Choe
Korean J Pediatr Gastroenterol Nutr.2004;7(2):197-207.   Published online 2004 September 30     DOI: http://dx.doi.org/10.5223/kjpgn.2004.7.2.197
      

 1 of 1